COMBINATION COMPRISING PALMITOYLETHANOLAMIDE (PEA) AND LYCOPENE FOR USE IN THE TREATMENT OF INFLAMMATORY DISEASES
The object of the present invention is the combination of palmitoylethanolamide (PEA) and lycopene, and/or pharmaceutically acceptable salts and/or derivatives thereof, the pharmaceutical formulations comprising the combination of PEA and lycopene, and/or pharmaceutically acceptable salts or derivat...
Gespeichert in:
| Hauptverfasser: | , , |
|---|---|
| Format: | Patent |
| Sprache: | eng ; fre |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | MIGLIACCIO, RAFFAELE MIGLIACCIO, CARMELA SARDEI, ANTONELLA |
| description | The object of the present invention is the combination of palmitoylethanolamide (PEA) and lycopene, and/or pharmaceutically acceptable salts and/or derivatives thereof, the pharmaceutical formulations comprising the combination of PEA and lycopene, and/or pharmaceutically acceptable salts or derivatives thereof, optionally together with at least one pharmacologically acceptable excipient, and the use of the combination of PEA and lycopene, and/or pharmaceutically acceptable salts or derivatives thereof, and of the formulations comprising such a combination, in the treatment of inflammatory diseases.
L'objet de la présente invention est la combinaison de palmitoyléthanolamide (PEA) et de lycopène, et/ou des sels pharmaceutiquement acceptables et/ou des dérivés de ceux-ci, les formulations pharmaceutiques comprenant la combinaison de PEA et de lycopène, et/ou des sels pharmaceutiquement acceptables ou dérivés de ceux-ci, facultativement avec au moins un excipient pharmacologiquement acceptable, et l'utilisation de la combinaison de PEA et du lycopène, et/ou des sels pharmaceutiquement acceptables ou dérivés de ceux-ci, et des formulations comprenant une telle combinaison, dans le traitement de maladies inflammatoires. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_CA2986371C</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>CA2986371C</sourcerecordid><originalsourceid>FETCH-epo_espacenet_CA2986371C3</originalsourceid><addsrcrecordid>eNqFi70KwjAURrs4iPoM3lEHBy34M17TGxtIbkJyHTqVInESrdT3xw7uTt_hcL5p8VbenQ2jGM8wcogmGb5AQOuM-MaS1MjeojMVwSoQrgG5AtsoH4gJtI9wTQSGQWoCiYTiiAW8Hp0ejw7FxwYqkwgTpXkxuXePIS9-OyuWmkTVm9y_2jz03S0_86dVuDsd9-Vhq8r_xRdCqzdM</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>COMBINATION COMPRISING PALMITOYLETHANOLAMIDE (PEA) AND LYCOPENE FOR USE IN THE TREATMENT OF INFLAMMATORY DISEASES</title><source>esp@cenet</source><creator>MIGLIACCIO, RAFFAELE ; MIGLIACCIO, CARMELA ; SARDEI, ANTONELLA</creator><creatorcontrib>MIGLIACCIO, RAFFAELE ; MIGLIACCIO, CARMELA ; SARDEI, ANTONELLA</creatorcontrib><description>The object of the present invention is the combination of palmitoylethanolamide (PEA) and lycopene, and/or pharmaceutically acceptable salts and/or derivatives thereof, the pharmaceutical formulations comprising the combination of PEA and lycopene, and/or pharmaceutically acceptable salts or derivatives thereof, optionally together with at least one pharmacologically acceptable excipient, and the use of the combination of PEA and lycopene, and/or pharmaceutically acceptable salts or derivatives thereof, and of the formulations comprising such a combination, in the treatment of inflammatory diseases.
L'objet de la présente invention est la combinaison de palmitoyléthanolamide (PEA) et de lycopène, et/ou des sels pharmaceutiquement acceptables et/ou des dérivés de ceux-ci, les formulations pharmaceutiques comprenant la combinaison de PEA et de lycopène, et/ou des sels pharmaceutiquement acceptables ou dérivés de ceux-ci, facultativement avec au moins un excipient pharmacologiquement acceptable, et l'utilisation de la combinaison de PEA et du lycopène, et/ou des sels pharmaceutiquement acceptables ou dérivés de ceux-ci, et des formulations comprenant une telle combinaison, dans le traitement de maladies inflammatoires.</description><language>eng ; fre</language><subject>HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2022</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20220503&DB=EPODOC&CC=CA&NR=2986371C$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20220503&DB=EPODOC&CC=CA&NR=2986371C$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>MIGLIACCIO, RAFFAELE</creatorcontrib><creatorcontrib>MIGLIACCIO, CARMELA</creatorcontrib><creatorcontrib>SARDEI, ANTONELLA</creatorcontrib><title>COMBINATION COMPRISING PALMITOYLETHANOLAMIDE (PEA) AND LYCOPENE FOR USE IN THE TREATMENT OF INFLAMMATORY DISEASES</title><description>The object of the present invention is the combination of palmitoylethanolamide (PEA) and lycopene, and/or pharmaceutically acceptable salts and/or derivatives thereof, the pharmaceutical formulations comprising the combination of PEA and lycopene, and/or pharmaceutically acceptable salts or derivatives thereof, optionally together with at least one pharmacologically acceptable excipient, and the use of the combination of PEA and lycopene, and/or pharmaceutically acceptable salts or derivatives thereof, and of the formulations comprising such a combination, in the treatment of inflammatory diseases.
L'objet de la présente invention est la combinaison de palmitoyléthanolamide (PEA) et de lycopène, et/ou des sels pharmaceutiquement acceptables et/ou des dérivés de ceux-ci, les formulations pharmaceutiques comprenant la combinaison de PEA et de lycopène, et/ou des sels pharmaceutiquement acceptables ou dérivés de ceux-ci, facultativement avec au moins un excipient pharmacologiquement acceptable, et l'utilisation de la combinaison de PEA et du lycopène, et/ou des sels pharmaceutiquement acceptables ou dérivés de ceux-ci, et des formulations comprenant une telle combinaison, dans le traitement de maladies inflammatoires.</description><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2022</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqFi70KwjAURrs4iPoM3lEHBy34M17TGxtIbkJyHTqVInESrdT3xw7uTt_hcL5p8VbenQ2jGM8wcogmGb5AQOuM-MaS1MjeojMVwSoQrgG5AtsoH4gJtI9wTQSGQWoCiYTiiAW8Hp0ejw7FxwYqkwgTpXkxuXePIS9-OyuWmkTVm9y_2jz03S0_86dVuDsd9-Vhq8r_xRdCqzdM</recordid><startdate>20220503</startdate><enddate>20220503</enddate><creator>MIGLIACCIO, RAFFAELE</creator><creator>MIGLIACCIO, CARMELA</creator><creator>SARDEI, ANTONELLA</creator><scope>EVB</scope></search><sort><creationdate>20220503</creationdate><title>COMBINATION COMPRISING PALMITOYLETHANOLAMIDE (PEA) AND LYCOPENE FOR USE IN THE TREATMENT OF INFLAMMATORY DISEASES</title><author>MIGLIACCIO, RAFFAELE ; MIGLIACCIO, CARMELA ; SARDEI, ANTONELLA</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_CA2986371C3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; fre</language><creationdate>2022</creationdate><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>MIGLIACCIO, RAFFAELE</creatorcontrib><creatorcontrib>MIGLIACCIO, CARMELA</creatorcontrib><creatorcontrib>SARDEI, ANTONELLA</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>MIGLIACCIO, RAFFAELE</au><au>MIGLIACCIO, CARMELA</au><au>SARDEI, ANTONELLA</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>COMBINATION COMPRISING PALMITOYLETHANOLAMIDE (PEA) AND LYCOPENE FOR USE IN THE TREATMENT OF INFLAMMATORY DISEASES</title><date>2022-05-03</date><risdate>2022</risdate><abstract>The object of the present invention is the combination of palmitoylethanolamide (PEA) and lycopene, and/or pharmaceutically acceptable salts and/or derivatives thereof, the pharmaceutical formulations comprising the combination of PEA and lycopene, and/or pharmaceutically acceptable salts or derivatives thereof, optionally together with at least one pharmacologically acceptable excipient, and the use of the combination of PEA and lycopene, and/or pharmaceutically acceptable salts or derivatives thereof, and of the formulations comprising such a combination, in the treatment of inflammatory diseases.
L'objet de la présente invention est la combinaison de palmitoyléthanolamide (PEA) et de lycopène, et/ou des sels pharmaceutiquement acceptables et/ou des dérivés de ceux-ci, les formulations pharmaceutiques comprenant la combinaison de PEA et de lycopène, et/ou des sels pharmaceutiquement acceptables ou dérivés de ceux-ci, facultativement avec au moins un excipient pharmacologiquement acceptable, et l'utilisation de la combinaison de PEA et du lycopène, et/ou des sels pharmaceutiquement acceptables ou dérivés de ceux-ci, et des formulations comprenant une telle combinaison, dans le traitement de maladies inflammatoires.</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng ; fre |
| recordid | cdi_epo_espacenet_CA2986371C |
| source | esp@cenet |
| subjects | HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
| title | COMBINATION COMPRISING PALMITOYLETHANOLAMIDE (PEA) AND LYCOPENE FOR USE IN THE TREATMENT OF INFLAMMATORY DISEASES |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-20T10%3A00%3A13IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=MIGLIACCIO,%20RAFFAELE&rft.date=2022-05-03&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3ECA2986371C%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |